Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell ...
The identification of CD8+ TIGR cells yields new insights into organ-specific immune regulation and potential therapeutics for inflammatory bowel disease.
A new Northwestern Medicine study has uncovered how a key immunoregulatory receptor plays an unexpected dual role in ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and Sonoma Biotherapeutics, Inc., a ...
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized ...
CoRegen, Inc., a biopharmaceutical company pursuing novel treatments for patients living with some of the most aggressive forms of cancer, today announced the U.S. Food and Drug Administration (FDA) ...
Hattie Chung, PhD, began her journey to becoming a scientist at the age of eight when she moved from Seoul, South Korea, to ...
Introduction Patients with SLE have an increased risk of infections and infection-related mortality, which may be associated ...
Money.ca on MSN
Stem-cell tourism is costing Canadians tens of thousands — and more, especially when multiple risks can outweigh the results
From TikTok testimonials to $30,000 trips abroad, more Canadians are chasing experimental treatments that Health Canada ...
Gov. Mike Braun flung open the prison's doors to house ICE detainees. Medical staffers said they were unprepared for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results